Kerentanan Schistosoma japonicum terhadap Praziquantel di Napu dan Lindu, Sulawesi Tengah Indonesia

Kerentanan Schistosoma japonicum terhadap Praziquantel di Napu dan Lindu, Sulawesi Tengah Indonesia

Show other versions (1)

Schistosomiasis in Indonesia are found in Napu, Lindu and Bada highland, Central Sulawesi. This disease was caused by Trematode worm, Schistosoma japonicum. Schistosomiasis still a public health problem which its prevalence increase every year. The large scale treatment by mass chemotherapy using pr...

Full description

Bibliographic Details
Main Authors:	Anis Nurwidayati, Triwibowo AG, Phetisya PFS, Risti Risti
Format:	Article
Language:	Indonesian
Published:	Balai Litbang P2B2 Banjarnegara 2016-07-01
Series:	Balaba: Jurnal Litbang Pengendalian Penyakit Bersumber Binatang Banjarnegara
Subjects:	Susceptibility praziquantel schistosomiasis
Online Access:	http://ejournal.litbang.depkes.go.id/index.php/blb/article/view/4455

Similar Items

Kerentanan Schistosoma japonicum terhadap Praziquantel di Napu dan Lindu, Sulawesi Tengah Indonesia
by: Anis Nurwidayati, et al.
Published: (2016-07-01)

MicroRNA-21 Mediates the Inhibiting Effect of Praziquantel on NLRP3 Inflammasome in Schistosoma japonicum Infection
by: Delong Kong, et al.
Published: (2020-02-01)

Praziquantel is an effective drug for the treatment of Schistosoma Mansoni infection among school-aged children in Northwest Ethiopia
by: Addisu Tesfie, et al.
Published: (2020-04-01)

Tingkat Infestasi Schistosomiasis Pada Tikus di Daerah Endemis Napu, Kabupaten Poso, Provinsi Sulawesi Tengah
by: Anis Nurwidayati, et al.
Published: (2020-06-01)

Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
by: Samuel Nkansah Darko, et al.
Published: (2020-05-01)

Morphological Characteristics of Schistosoma mansoni PZQ-resistant and -susceptible Strains are Different in Presence of Praziquantel
by: António ePinto-Almeida, et al.
Published: (2016-04-01)

Therapeutical evaluation of different dose regimens of praziquantel in schistosomiasis mansoni, based on the quantitative oogram technique
by: Aloísio Sales da Cunha, et al.
Published: (1987-10-01)

Praziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug
by: Ibrahim N. Mwangi, et al.
Published: (2014-12-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: Charles H. King, et al.
Published: (2000-12-01)

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa
by: Iran Mendonça da Silva, et al.
Published: (2005-07-01)

Review Artikel : Perkembangan Vaksin untuk Schistosoma japonicum
by: Anis Nurwidayati
Published: (2017-02-01)

Hubungan Perilaku Anak Sekolah Dasar dengan Kejadian Schistosomiasis di Kecamatan Lindu Kabupaten Sigi, Sulawesi Tengah
by: Octaviani Octaviani, et al.
Published: (2017-12-01)

Efficacy and Safety of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection among School Children in Tanzania
by: Rajabu Hussein Mnkugwe, et al.
Published: (2019-12-01)

Desenvolvimento de hidrogéis de dextrano contendo praziquantel
by: Campos, Flávio dos Santos [UNESP]
Published: (2014)

Síntese do anti-helmíntico praziquantel,a partir da glicina
by: Novaes Maria Rita Carvalho Garbi, et al.
Published: (1999-01-01)

In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
by: Xiaoli Wang, et al.
Published: (2019-05-01)

Pengetahuan Masyarakat Lindu terkait Schistosomiasis di Kabupaten Sigi Sulawesi Tengah
by: Ningsi Barmawi, et al.
Published: (2017-12-01)

Spatial distribution of Schistosoma mansoni infection before and after chemotherapy with two praziquantel doses in a community of Pernambuco, Brazil
by: Aline F Galvão, et al.
Published: (2010-07-01)

Comparação entre praziquantel e oxamniquine no tratamento da esquistossomose mansoni
by: Antônio Emanuel, et al.
Published: (1983-06-01)

Synthesis and SAR Studies of Praziquantel Derivatives with Activity against Schistosoma japonicum
by: Chuan-Xin Yu, et al.
Published: (2013-07-01)

Humoral responses to Schistosoma japonicum soluble egg antigens in domestic animals in Lindu Subdistrict, Central Sulawesi Province, Indonesia
by: Novericko Ginger Budiono, et al.
Published: (2020-08-01)

Treatment of patients with Schistosomiasis mansoni: a double blind clinical trial comparing praziquantel with oxamniquine
by: Luiz Caetano da Silva, et al.
Published: (1986-06-01)

Pengetahuan Masyarakat tentang Schistosomiasis di Desa Winowanga, Dataran Tinggi Napu Sulawesi Tengah
by: Made Agus Nurjana
Published: (2017-08-01)

Comparative randomised trial of high and conventional doses of praziquantel in the treatment of schistosomiasis mansoni
by: Leonardo C de Queiroz, et al.
Published: (2010-07-01)

Schistosoma gallbladder polyp masquerading as a neoplasm: Rare case report and literature review
by: Gawahir A. Ali, et al.
Published: (2021-07-01)

Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: research and development of a pediatric formulation of praziquantel
by: Jutta Reinhard-Rupp, et al.
Published: (2017-08-01)

Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis
by: Robert Bergquist, et al.
Published: (2018-12-01)

Baixa eficácia da associação oxamniquine e praziquantel na cura da esquistossomose mansônica
by: R. Dietze, et al.
Published: (1986-12-01)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
by: Adriana Maria B. MENDONÇA, et al.
Published: (2016-01-01)

Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda
by: Christina L. Faust, et al.
Published: (2019-12-01)

Schistosomiasis haematobia: histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed Esquistossomíase hematóbica: seguimento histopatológico determinado por cistoscopia em um paciente com falha terapêutica ao praziquantel
by: Iran Mendonça da Silva, et al.
Published: (2008-12-01)

Ground Calcium Carbonate as a Low Cost and Biosafety Excipient for Solubility and Dissolution Improvement of Praziquantel
by: Ana Borrego-Sánchez, et al.
Published: (2019-10-01)

Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies
by: Shu-Hua Xiao, et al.
Published: (2018-02-01)

Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
by: Robert Bergquist, et al.
Published: (2017-03-01)

Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
by: Mark S. Pearson, et al.
Published: (2021-05-01)

The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
by: Emily L. Webb, et al.
Published: (2021-09-01)

Avaliação do efeito do praziquantel associado a lipossomas em Schistosoma mansoni in vivo
by: Frezza, Tarsila Ferraz, 1983-
Published: (2007)

KAJIAN HUBUNGAN ANTARA DAERAH PERINDUKAN KEONG PERANTARA SCHISTOSOMIASIS TERHADAP KEJADIAN SCIDSTOSOMIASIS DI NAPU, KABUPATEN POSO, SULAWESI TENGAH
by: Anis Nurwidayati
Published: (2012-10-01)

Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis
by: Zhao Qin-Ping, et al.
Published: (2011-10-01)

Solid dispersions with hydrogenated castor oil increase solubility, dissolution rate and intestinal absorption of praziquantel
by: Marco Vinicius Chaud, et al.
Published: (2010-09-01)